The Department of Pharmacology offers one of the country's top-rated graduate programs, teaches undergraduate students, and conducts high-impact research.

  • Congratulations to our graduating Pharmacology minors!

    Neil Anderson, Jessica Bentley, Stephanie Breunig, Mitchell Budde, Angela Burt, Austin Cossalter, Jeffrey Gaynes, Elizabeth Hartell, Seokwon Jo, Joshi Shilvi, Cedrik Krouch, Qianqian Ma, Avinash Persaud, Joshua Policarpio, Taylor Takasugi, Michael Tobin, Joseph Voth, Zachary Weinstock, Marissah Wood, and Andrew Zhou.

  • Congratulations to Dr. Colin Campbell

    Recipient of the “President’s Award for Outstanding Service”

  • Cancer and Cardioivascular Research Building

    The Cancer and Cardiovascular Research Building (CCRB), a new facility that houses cancer research in pharmacology.

  • Nils Hasselmo Hall (NHH)

    A major research building for the department.

What is pharmacology?

Pharmacology explores the mechanisms that drugs use to cause therapeutic effects.

The basic principle of pharmacology is that therapeutic agents are effective because they mimic or block molecules that regulate natural processes like blood pressure, organ development, and pain perception.

Who we are and what we do

Research and discovery

Why PharmacologyWe conduct high-impact research that advances the fundamental knowledge of drug action.

Education programs

We provide high quality teaching of the principles of pharmacology and the application of pharmacology to the biomedical sciences.

News and events

Pharmacology Student Seminar - Targeting two-pore channels to inhibit MERS-Coronavirus cell entry

Gihan Gunaratne
2nd Year Ph.D. Student
Department of Pharmacology
University of Minnesota

Wednesday, July 27th
12:00 pm - 1:00 pm
2-137 Jackson Hall

Pharmacology Department Pilot Program in Drug Discovery Awardees

The Department of Pharmacology has established drug discovery as an area of strategic importance for future growth and success of the department. To that end it has decided to provide seed money for new drug discovery efforts (not currently funded through existing grants) that have high potential for future funding. 

Three primary faculty have been awarded funding through the department's new Pilot Program in Drug Discovery:

  • Dr. Hiroshi Hiasa
  • Dr. Jonathan Marchant
  • Dr. Li-Na Wei

Please congratulate them on this funding and wish them best of luck as they begin their research!

An investigator-initiated clinical trial is opening at the Masonic Cancer Center based on research conducted by the laboratory of Dr. Jill Siegfried

The trial will be led by Dr. Manish Patel and is entitled: "Phase II Trial of Exemestane in Previously Treated Post-Menopausal Women with advanced Non-Small Cell Lung Cancer"

Dr. Aaron LeBeau has been awarded a Paul Calabresi K12 Award in Clinical-Translational Research at Mayo Clinic by the National Cancer Institute